| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0016-5085(92)91184-6 |
| P698 | PubMed publication ID | 1358743 |
| P50 | author | Peter S. Rabinovitch | Q67522938 |
| P2093 | author name string | G C Burmer | |
| R C Haggitt | |||
| V R Kolli | |||
| C E Rubin | |||
| A C Stevens | |||
| D A Crispin | |||
| T A Brentnall | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ulcerative colitis | Q1477 |
| P304 | page(s) | 1602-1610 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele | |
| P478 | volume | 103 |
| Q39025783 | A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer |
| Q30931923 | A note from history: Landmarks in history of cancer, part 7. |
| Q38440526 | Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation |
| Q73555769 | Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis |
| Q42149870 | Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer |
| Q26865465 | Advanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped? |
| Q51743145 | An Update on Surveillance in Ulcerative Colitis. |
| Q34100636 | Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors. |
| Q71875917 | Assessment of Dysplasia, Mucosal Mucins, p53 Protein Expression, and DNA Content in Ulcerative Colitis Patients with Colectomy and Ileorectal Anastomosis |
| Q77900861 | Biology of colorectal cancer in ulcerative colitis |
| Q40890839 | Cancer biology in ulcerative colitis and potential use in endoscopic surveillance. |
| Q72824184 | Cancer in inflammatory bowel disease |
| Q37464715 | Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer |
| Q35047726 | Chemistry meets biology in colitis-associated carcinogenesis |
| Q38973304 | Clonal evolution of colorectal cancer in IBD. |
| Q37451607 | Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis |
| Q37426977 | Clonal expansions in ulcerative colitis identify patients with neoplasia |
| Q35169025 | Colitis-associated neoplasia: molecular basis and clinical translation |
| Q52678768 | Colon Cancer: Inflammation-Associated Cancer. |
| Q37164065 | Colonic crypt organization and tumorigenesis |
| Q30245054 | Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management |
| Q88549068 | Colorectal Cancer in Inflammatory Bowel Disease |
| Q39201673 | Colorectal cancer in a population with endemic Schistosoma mansoni: is this an at-risk population? |
| Q37122138 | Colorectal cancer surveillance in inflammatory bowel disease: the search continues |
| Q39264260 | Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysis. |
| Q40916028 | Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects. |
| Q73341077 | Cytology and image cytometry after colonic lavage: a complementary diagnostic tool in patients with ulcerative colitis |
| Q35748992 | DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free |
| Q60697114 | DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis |
| Q41898418 | DPC4 gene mutation in colitis associated neoplasia |
| Q35833386 | Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas |
| Q35105993 | Diagnostic Problems and Advances in Inflammatory Bowel Disease |
| Q73823192 | Diagnostic value of DNA image cytometry in ulcerative colitis |
| Q35541869 | Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer |
| Q35677977 | Differentiating a chronic hyperplastic mass from pancreatic cancer: a challenge remaining in multidetector CT of the pancreas |
| Q35355424 | Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis |
| Q34124381 | Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis |
| Q38619582 | Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. |
| Q73670201 | Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer |
| Q35589080 | Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis |
| Q72642714 | Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease |
| Q34104498 | Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. |
| Q47258476 | Flow cytometric enrichment for respiratory epithelial cells in sputum. |
| Q26750514 | Gastrointestinal stem cells in health and disease: from flies to humans |
| Q37331686 | Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions. |
| Q35763613 | Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps |
| Q40491982 | Genetics, molecular biology and colorectal cancer |
| Q37061118 | Genomic biomarkers to improve ulcerative colitis neoplasia surveillance. |
| Q55516972 | Genomic characterization of colitis-associated colorectal cancer. |
| Q35787099 | Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia |
| Q43006455 | Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. |
| Q39741804 | IBD-related carcinoma and lymphoma |
| Q92134302 | Inflammatory bowel disease- and Barrett's esophagus-associated neoplasia: the old, the new, and the persistent struggles |
| Q34131254 | Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences |
| Q37024833 | Inflammatory bowel disease: the problems of dysplasia and surveillance |
| Q34662592 | Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis |
| Q48891455 | Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study |
| Q82661371 | Is ulcerative colitis associated with survival among older persons with colorectal cancer in the US? A population-based case-control study |
| Q35833643 | K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis |
| Q72114682 | K-ras-2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas |
| Q33591865 | KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis |
| Q77321909 | Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas |
| Q26775937 | MicroRNA in inflammatory bowel disease: Translational research and clinical implication |
| Q73534953 | Microsatellite instability is uncommon in intestinal mucosa of patients with Crohn's disease |
| Q38201709 | Microscopic features of colorectal neoplasia in inflammatory bowel diseases |
| Q37106795 | Mitochondria and tumor progression in ulcerative colitis. |
| Q55313051 | Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis. |
| Q35806727 | Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. |
| Q34298903 | O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms |
| Q33962407 | Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma |
| Q53181025 | Precancer in ulcerative colitis: the role of the field effect and its clinical implications. |
| Q44535164 | R72P polymorphism of TP53 in ulcerative colitis patients is associated with the incidence of colectomy, use of steroids and the presence of a positive family history. |
| Q35097371 | Radical causes of cancer. |
| Q73501769 | Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation |
| Q74524939 | Risk of cancer in ulcerative colitis |
| Q38669208 | Role of Intestinal HIF-2α in Health and Disease |
| Q35753502 | Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation |
| Q42065620 | Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view |
| Q36673593 | TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva |
| Q37485252 | Telomere shortening correlates to dysplasia but not to DNA aneuploidy in longstanding ulcerative colitis |
| Q38213491 | The contribution of neuronal-glial-endothelial-epithelial interactions to colon carcinogenesis |
| Q41685824 | The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study |
| Q35829456 | The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia |
| Q34802663 | Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. |
| Q37597639 | miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes |
| Q35788130 | p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis |
| Q36788267 | p53 expression in ulcerative colitis: a longitudinal study |
| Q36901659 | p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease |
Search more.